Oxford, AstraZeneca Coronavirus Vaccine Produces Immune Response in Adults
In an update this Monday, the University of Oxford and British drugmaker AstraZeneca announced that their experimental COVID-19 vaccine produces a similar immune response in both older and younger adults.
The current University of Oxford vaccine, also known as, AZD1222, is considered a frontrunner in the race to protect people around the world from the virus. The news today gives us a glimmer of hope as many countries around the world deal with a new wave of COVID-19.
“It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the COVID-19 disease severity is higher,” says a representative from AstraZeneca in an article for Reuters.
“The results further build the body of evidence for the safety and immunogenicity of AZD1222."